Parainfluenza virus 5 expressing the G protein of rabies virus protects mice after rabies virus infection

Journal of Virology

Volumn 89, Issue 6, 2015, Pages 3427-3429

  Huang, Ying ^a   Chen, Zhenhai ^a   Huang, Junhua ^a   Fu, ZhenFang ^a   He, Biao ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RABIES IMMUNOGLOBULIN; RECOMBINANT PARAINFLUENZA VIRUS 5 VIRUS GLYCOPROTEIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; RABIES VACCINE; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG EFFICACY; MOUSE; NONHUMAN; PARAINFLUENZA VIRUS 5; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABIES; RABIES VIRUS; VIRUS GENOME; ANIMAL; GENE EXPRESSION; GENE VECTOR; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; VIROLOGY;

MUS; PARAINFLUENZA VIRUS; RABIES VIRUS;

ANIMALS; ANTIBODIES, VIRAL; GENE EXPRESSION; GENETIC VECTORS; HUMANS; MICE; PARAINFLUENZA VIRUS 5; RABIES; RABIES VACCINES; RABIES VIRUS; VIRAL ENVELOPE PROTEINS;

EID: 84923203487     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03656-14     Document Type: Article

References (25)

1. Meslin FX, Fisbein DB, Matter HC. 1994. Rationale and prospects for rabies elimination in developing countries. Curr Top Microbiol Immunol 187:1-26.
2. Anonymous. 1993. World survey of rabies 27. Veterinary Public Health Unit, WHO, Geneva, Switzerland.
3. WHO. 2010. Fact sheet no. 99. WHO, Geneva, Switzerland.
4. Rupprecht CE, Hanlon CA, Hemachudha T. 2002. Rabies re-examined. Lancet Infect Dis ii:327-343. http://dx.doi.org/10.1016/S1473-3099(02)00287-6.
5. Phares TW, Kean RB, Mikheeva T, Hooper DC. 2006. Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J Immunol 176: 7666-7675. http://dx.doi.org/10.4049/jimmunol.176.12.7666.
6. Faber M, Li J, Kean RB, Hooper DC, Alugupalli KR, Dietzschold B. 2009. Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus. Proc Natl Acad Sci U S A 106:11300-11305. http://dx.doi.org/10.1073/pnas.0905640106.
7. Wen Y, Wang H, Wu H, Yang F, Tripp RA, Hogan RJ, Fu ZF. 2011. Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination. J Virol 85:1634-1644. http://dx.doi.org/10.1128/JVI.01552-10.
8. Wang H, Zhang G, Wen Y, Yang S, Xia X, Fu ZF. 2011. Intracerebral administration of recombinant rabies virus expressing GM-CSF prevents the development of rabies after infection with street virus. PLoS One 6:e25414. http://dx.doi.org/10.1371/journal.pone.0025414.
9. Lamb RA, Kolakofsky D. 2001. Paramyxoviridae: the viruses and their replication. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
10. Binn LN, Eddy GA, Lazar EC, Helms J, Murnane T. 1967. Viruses recovered from laboratory dogs with respiratory disease. Proc Soc Exp Biol Med 126:140-145. http://dx.doi.org/10.3181/00379727-126-32386.
11. Rosenberg FJ, Lief FS, Todd JD, Reif JS. 1971. Studies of canine respiratory viruses. I. Experimental infection of dogs with an SV5-like canine parainfluenza agent. Am J Epidemiol 94:147-165.
12. Cornwell HJ, McCandlish IA, Thompson H, Laird HM, Wright NG. 1976. Isolation of parainfluenza virus SV5 from dogs with respiratory disease. Vet Rec 98:301-302. http://dx.doi.org/10.1136/vr.98.15.301.
13. McCandlish IA, Thompson H, Cornwell HJ, Wright NG. 1978. A study of dogs with kennel cough. Vet Rec 102:293-301. http://dx.doi.org/10 .1136/vr.102.14.293.
14. Azetaka M, Konishi S. 1988. Kennel cough complex: confirmation and analysis of the outbreak in Japan. Nippon Juigaku Zasshi 50:851-858. http://dx.doi.org/10.1292/jvms1939.50.851.
15. Chladek DW, Williams JM, Gerber DL, Harris LL, Murdock FM. 1981. Canine parainfluenza-Bordetella bronchiseptica vaccine immunogenicity. Am J Vet Res 42:266-270.
16. Kontor EJ, Wegrzyn RJ, Goodnow RA. 1981. Canine infectious tracheobronchitis: effects of an intranasal live canine parainfluenza-Bordetella bronchiseptica vaccine on viral shedding and clinical tracheobronchitis (kennel cough). Am J Vet Res 42:1694-1698.
17. He B, Paterson RG, Ward CD, Lamb RA. 1997. Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology 237: 249-260. http://dx.doi.org/10.1006/viro.1997.8801.
18. Phan SI, Chen Z, Xu P, Li Z, Gao X, Foster SL, Teng MN, Tripp RA, Sakamoto K, He B. 2014. A respiratory syncytial virus (RSV) vaccine based on parainfluenza virus 5 (PIV5). Vaccine 32:3050-3057. http://dx .doi.org/10.1016/j.vaccine.2014.03.049.
19. Chen Z, Zhou M, Gao X, Zhang G, Ren G, Gnanadurai CW, Fu ZF, He B. 2013. A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein. J Virol 87:2986-2993. http://dx.doi.org/10.1128/JVI.02886-12.
20. Chai Q, He WQ, Zhou M, Lu H, Fu ZF. 2014. Enhancement of bloodbrain barrier permeability and reduction of tight junction protein expression are modulated by chemokines/cytokines induced by rabies virus infection. J Virol 88:4698-4710. http://dx.doi.org/10.1128/JVI.03149-13.
21. Vos A, Muller T, Schuster P, Selhorst T, Wenzel U. 2001. Maternal immunity against rabies in raccoon dogs. Acta Vet Hung 49:291-294. http://dx.doi.org/10.1556/AVet.49.2001.3.5.
22. Aghomo HO, Oduye OO, Rupprecht CE. 1990. The serological response of young dogs to the Flury LEP strain of rabies virus vaccine. Vet Res Commun 14:415-425. http://dx.doi.org/10.1007/BF00343220.
23. Young DF, Randall RE, Hoyle JA, Souberbielle BE. 1990. Clearance of a persistent paramyxovirus infection is mediated by cellular immune responses but not by serum-neutralizing antibody. J Virol 64:5403-5411.
24. Tompkins SM, Lin Y, Leser GP, Kramer KA, Haas DL, Howerth EW, Xu J, Kennett MJ, Durbin RK, Durbin JE, Tripp R, Lamb RA, He B. 2007. Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge. Virology 362:139-150. http://dx.doi.org/10.1016/j.virol.2006 .12.005.
25. Li Z, Mooney AJ, Gabbard JD, Gao X, Xu P, Place RJ, Hogan RJ, Tompkins SM, He B. 2013. Recombinant parainfluenza virus 5 expressing hemagglutinin of influenzaAvirus H5N1 protected mice against lethal highly pathogenic avian influenza virus H5N1 challenge. J Virol 87:354-362. http://dx.doi.org/10.1128/JVI.02321-12.